🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Jubilant Ingrevia Ltd (JUBN)

BSE
Currency in INR
Disclaimer
731.85
-62.40(-7.86%)
Delayed Data
JUBN Scorecard
Full Analysis
Trading at a high earnings multiple
Earnings results expected in 15 days
Fair Value
Day's Range
716.80818.00
52 wk Range
407.00836.95
Bid/Ask
731.00 / 732.30
Prev. Close
794.25
Open
818
Day's Range
716.8-818
52 wk Range
407-836.95
Volume
50,201
Average Volume (3m)
89,943
1-Year Change
63.93%
Fair Value
Unlock
Fair Value Upside
Unlock
JUBN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
780.33
Upside
+6.68%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Chemicals industry
Show more

Jubilant Ingrevia Ltd Company Profile

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. The company provides piperidines, metal complexes, choline salts, vitamin B3, Vitamin B4, picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, formaldehyde, bio acetic acid-food grade, acetaldehyde, and ethanol, as well as cyano, acetyl, amino, halo, alkyl, and aldehyde pyridines. In addition, it offers route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.

Industry
Chemicals
Employees
2295
Market
India

Compare JUBN to Peers and Sector

Metrics to compare
JUBN
Peers
Sector
Relationship
P/E Ratio
72.1x41.1x0.1x
PEG Ratio
−1.860.060.00
Price/Book
4.6x3.4x1.6x
Price / LTM Sales
3.1x4.0x1.3x
Upside (Analyst Target)
6.9%8.8%24.1%
Fair Value Upside
Unlock−9.2%0.4%Unlock

FAQ

What Is the Jubilant Ingrevia (JUBN) Stock Price Today?

The Jubilant Ingrevia stock price today is 731.85.

What Stock Exchange Does Jubilant Ingrevia Trade On?

Jubilant Ingrevia is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Jubilant Ingrevia?

The stock symbol for Jubilant Ingrevia is "JUBN."

Does Jubilant Ingrevia Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.63%.

What Is the Jubilant Ingrevia Market Cap?

As of today, Jubilant Ingrevia market cap is 125.51B.

What is Jubilant Ingrevia Earnings Per Share?

The Jubilant Ingrevia EPS is 11.01.

What Is the Next Jubilant Ingrevia Earnings Date?

Jubilant Ingrevia will release its next earnings report on 21 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.